Question 1

What is Dalbavancin?

Accepted Answer

Dalbavancin is a medication classified as a glycopeptide antibiotic. It functions by interfering with the way bacteria build their cell walls, which prevents the bacteria from growing and helps the body clear the infection.

This medication is designed to target specific types of bacteria and is not effective against viral infections. It belongs to a subclass of antibiotics known as lipoglycopeptides.

Question 2

What is Dalbavancin used for?

Accepted Answer

Dalbavancin is used to treat acute bacterial skin and skin structure infections.

Question 3

How does Dalbavancin work?

Accepted Answer

How Dalbavancin Fights Infection

Dalbavancin belongs to a class of medications known as lipoglycopeptide antibiotics. It is specifically designed to treat acute bacterial skin and skin structure infections caused by certain types of Gram-positive bacteria.

Inhibiting Cell Wall Synthesis

Bacteria require a strong, rigid outer layer called a cell wall to survive, maintain their shape, and protect themselves from their environment. Dalbavancin works by interfering with the process bacteria use to build these walls. It binds to specific building blocks within the bacterial cell, preventing them from being linked together to form a stable structure.

Bacterial Death

When the construction of the cell wall is interrupted, the bacteria can no longer maintain their integrity. This process results in:

Cellular breakdown: Without a functional cell wall, the bacterial cell eventually bursts and dies.

Bactericidal action: Because dalbavancin actively kills the bacteria rather than just slowing their growth, it is classified as a bactericidal antibiotic.

Stopping the spread: By killing the bacteria at the site of the infection, the medication prevents the bacteria from multiplying and spreading to other parts of the body.

Dalbavancin is known for having a long half-life, which means it stays active in the body for an extended period to continue fighting the infection. It is important to note that this medication only works against bacterial infections and is not effective against viral infections, such as the common cold or the flu.

Question 4

What are the brand names for Dalbavancin?

Accepted Answer

Dalbavancin is sold under the brand name Dalvance .

Question 5

What are the active ingredients in Dalbavancin?

Accepted Answer

The active ingredient in Dalbavancin is dalbavancin .

Question 6

What are the side effects of Dalbavancin?

Accepted Answer

Common side effects of Dalbavancin may include:

Nausea

Headache

Diarrhea

Always consult with a healthcare professional about potential side effects.

Question 7

What drug class is Dalbavancin?

Accepted Answer

Dalbavancin belongs to the lipoglycopeptide antibiotic drug class.

Question 8

What is the dosage of Dalbavancin and how do I take it?

Accepted Answer

Administration

Dalbavancin is given as an injection into a vein (intravenous infusion) by a healthcare provider in a medical setting, such as a hospital or clinic. The infusion process typically takes about 30 minutes to complete.

Dosing Schedule

This medication is usually administered in one of two ways:

As a single, one-time dose.

As two separate doses given one week apart.

Your healthcare provider will determine the most appropriate schedule based on your specific condition and medical history.

Missed Dose

Because this medication is administered by a healthcare professional, it is important to keep all scheduled appointments. If you miss an appointment for your infusion, contact your doctor or healthcare provider immediately to reschedule. Completing the full course of treatment as directed is essential to ensure the infection is fully cleared and to prevent the bacteria from becoming resistant to antibiotics.

Question 9

Is Dalbavancin safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There are no adequate and well-controlled studies regarding the use of dalbavancin in pregnant women. Animal studies have indicated that high doses of the medication may cause developmental issues, but these findings do not always predict human response. Healthcare providers typically only recommend dalbavancin during pregnancy when the clinical need is clear and the potential benefits outweigh the risks to the fetus.

Breastfeeding

It is not known if dalbavancin is present in human breast milk. While animal studies have shown that the drug is excreted in the milk of lactating rats, there is no specific data on its effects on nursing human infants. Individuals who are breastfeeding should discuss the potential risks and benefits with their doctor before starting treatment.

Question 10

What forms and strengths does Dalbavancin come in?

Accepted Answer

Available Forms

Dalbavancin is supplied as a sterile, lyophilized powder. It is contained in a single-dose vial and must be reconstituted and diluted by a healthcare professional before use.

Administration Method

This medication is administered only as an intravenous infusion. It is typically given by a healthcare provider in a clinical setting, such as a hospital or infusion center.

Question 11

What is the FDA approval status of Dalbavancin?

Accepted Answer

FDA Approval History

Dalbavancin was approved by the U.S. Food and Drug Administration (FDA) in May 2014. It was the first drug designated as a Qualified Infectious Disease Product (QIDP) to receive FDA approval under the Generating Antibiotic Incentives Now (GAIN) Act, which was designed to encourage the development of new antibacterial drugs.

Approved Indications

The medication is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible isolates of the following Gram-positive microorganisms:

Staphylococcus aureus (including methicillin-susceptible and methicillin-resistant strains)

Streptococcus pyogenes

Streptococcus agalactiae

Streptococcus dysgalactiae

The Streptococcus anginosus group (including S. anginosus , S. intermedius , and S. constellatus )

Pediatric Use

In 2021, the FDA expanded the approval of dalbavancin to include pediatric patients from birth. This allows for the treatment of ABSSSI in infants, children, and adolescents using weight-based dosing regimens.

Regulatory Status

Dalbavancin is a prescription-only medication that must be administered by a healthcare professional via intravenous infusion. There are currently no boxed warnings or Risk Evaluation and Mitigation Strategy (REMS) requirements associated with this drug.

Question 12

What should I know about Dalbavancin and cost?

Accepted Answer

Administration and Billing

Dalbavancin is an intravenous medication administered by healthcare professionals in clinical settings, such as hospitals or outpatient infusion centers. Because it is not typically dispensed through retail pharmacies, the cost is often billed as part of a medical procedure. The total price may include the medication itself along with fees for the infusion equipment and professional services.

Insurance Coverage

Most private insurance plans and government programs like Medicare cover dalbavancin when it is used for FDA-approved indications. Because it is administered in a clinic or hospital, it is usually covered under a patient's medical benefit rather than a standard prescription drug benefit. Out-of-pocket costs, such as deductibles or co-insurance, will vary depending on the specific terms of the individual's insurance policy.

Financial Assistance

Financial assistance programs may be available for patients who have difficulty covering the cost of treatment. These programs are often provided by the manufacturer or through the healthcare facility where the infusion is performed. Patients are encouraged to speak with their healthcare provider or the billing department at their treatment center to learn about available support options or payment plans.

Dalbavancin

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Brand Names

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Found an Error?